The smallcap and midcap indices continued their upward trend for the second consecutive day. Linde India and Windlas Biotech emerged as top gainers. Despite the Sensex and Nifty trading in the red, the BSE Smallcap index gained over 1%, reaching 45,960 from 45,455.83. Windlas Biotech saw a remarkable surge, rising nearly 15% to Rs 774 per share, briefly hitting Rs 811 before paring some gains. Other notable gainers included MTAR Tech, BL Kashyap, Archean Chemical Industries, and Thomas Cook, which saw increases of 10-12%.
Both indices formed bullish engulfing candlestick patterns, indicating a potential trend reversal. The Nifty Smallcap 100 index had previously declined over 20% from its 52-week highs due to weak quarterly earnings and persistent FII selling. However, recent indicators suggest a recovery. The Reserve Bank of India’s latest bulletin pointed to a pick-up in economic activity in the second half of the current financial year, which has positively impacted market sentiment.
In summary, the smallcap and midcap indices have shown resilience and growth, driven by strong performances from companies like Linde India and Windlas Biotech. The positive outlook for the retail sector, coupled with signs of economic recovery, has boosted investor confidence and market performance.